Related Experiment Video
Updated: Mar 28, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
1.4K
Parturition dysfunction in obesity: time to target the pathobiology.
Nicole S Carlson1, Teri L Hernandez2, K Joseph Hurt3
1Emory University, Nell Hodgson Woodruff School of Nursing, 1520 Clifton Road NE, Atlanta, GA, 30322, USA. Nicole.Carlson@emory.edu.
Reproductive Biology and Endocrinology : RB&E
|December 20, 2015
Summary
Obesity in women of childbearing age is linked to labor complications. This review explores the biological mechanisms behind obesity
Area of Science:
- Reproductive Biology
- Obstetrics
- Metabolic Disorders
Background:
- Over a third of US women of childbearing age are obese, increasing pregnancy risks.
- Obesity is associated with delayed labor onset, slow progress, and higher rates of cesarean delivery.
- The underlying biological mechanisms of obesity-induced parturition dysfunction are not well understood.
Purpose of the Study:
- To review the known and proposed biological effects of obesity on labor preparation, contraction, and endurance.
- To synthesize evidence from human and animal studies on obesity's impact on parturition signaling.
- To identify research gaps and potential therapeutic interventions for optimizing labor in obese women.
Main Methods:
- Literature review of clinical observations and experimental data.
- Synthesis of evidence from human and animal studies.
- Analysis of obesity's interaction with parturition signaling pathways.
Main Results:
- Obesity affects multiple stages of labor, including cervical ripening, myometrial contractility, and oxytocin receptor expression.
- Evidence suggests impaired prostaglandin response, strengthened amniotic membranes, and reduced myocyte function in obese individuals.
- While clinical effects are evident, underlying pathobiology requires further investigation.
Conclusions:
- Obesity significantly impacts labor physiology through various biological mechanisms.
- Further research into the pathobiology of obesity and parturition is crucial.
- Targeted therapeutic interventions may improve labor outcomes for obese women.
More Related Videos
Related Concept Videos
Pathophysiology of Diabetes
4.3K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.3K
Drug Dosing: Obese Patients
339
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
339
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
379
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
379
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
281
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
281
Obesity
1.5K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K

